Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (22)

2024

  1. Free PCR virus detection via few-layer bismuthene and tetrahedral DNA nanostructured assemblies

    Talanta, Vol. 269

  2. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  2. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2022

  1. Amplification-free detection of SARS-CoV-2 using gold nanotriangles functionalized with oligonucleotides

    Microchimica Acta, Vol. 189, Núm. 4

  2. CASCADE: Naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles

    Analytica Chimica Acta, Vol. 1205

  3. COVID-19: Some unresolved issues

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 421-434

  4. Development of colorimetric sensors based on gold nanoparticles for SARS-CoV-2 RdRp, E and S genes detection

    Talanta, Vol. 243

  5. Methylene Blue functionalized carbon nanodots combined with different shape gold nanostructures for sensitive and selective SARS-CoV-2 sensing

    Sensors and Actuators B: Chemical, Vol. 369

  6. Monkeypox in humans: a new outbreak

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 509-518

  7. Paving the way to point of care (POC) devices for SARS-CoV-2 detection

    Talanta, Vol. 247

2019

  1. Monitoring the antimicrobial susceptibility of gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the smart study (Spain, 2016 and 2017)

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 145-155

2018

  1. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 3, pp. 511-515

  2. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among gram-negative organisms recovered during the SMART study in Spain (2011-2015)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 136-145

2017

  1. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

2013

  1. In vitro activity of ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 12, pp. 6389-6392

2010

  1. Actividad comparativa de doripenem, meropenem e imipenem en aislados recientes obtenidos durante el estudio de vigilancia epidemiológica COMPACT-España

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 144-152

  2. Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis

    Journal of Clinical Microbiology, Vol. 48, Núm. 2, pp. 456-459

2009

  1. Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible staphylococcus aureus lung infection in a cystic fibrosis patient

    Pediatric Pulmonology, Vol. 44, Núm. 5, pp. 512-515

2007

  1. CTX-M: Changing the face of ESBLs in Europe

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 2, pp. 165-174